Te Matau a Māui | Laboratory Services - User contributions [en]

Tests:Von Willebrand Screen

2026-01-04T23:48:34Z

Glim:

{{DISPLAYTITLE:Von Willebrand Screen}}

[[Category:Tests]]
[[Category:Haematology]]
[[Category:CHL]]
{| class="wikitable"
|'''Synonym(s)'''
|VWD, Von Willebrands disease, vWF, vWF:Ag; vWF:RCo; von Willebrand Panel; Ristocetin Cofactor; vWF:RCof; Collagen binding; vWF:CBA
|-
|'''Specimen'''
|3 x 2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tubes must be FULL
Separated plasma - 2mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Turnaround Time'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Where analysed'''
|CHL
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|AI, HFIB, HF8 and COAG
|-
|'''Measurement Uncertainty'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Lab Notes'''
|Three 2.7ml citrated (BLUE top) collection tubes are required. The samples are registered for an INR, APTT, Fibrinogen and FVIII and sendaway test – registration codes AI, HFIB, HF8 and COAG
|}

Tests:Von Willebrand Screen

2026-01-04T23:48:13Z

Glim:

{{DISPLAYTITLE:Von Willebrand Screen}}

[[Category:Tests]]
[[Category:Haematology]]
[[Category:CHL]]
{| class="wikitable"
|'''Synonym(s)'''
|VWD, Von Willebrands disease, vWF, vWF:Ag; vWF:RCo; von Willebrand Panel; Ristocetin Cofactor; vWF:RCof; Collagen binding; vWF:CBA
|-
|'''Specimen'''
|3 x 2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tubes must be FULL
Separated plasma - 2mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Turnaround Time'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Where analysed'''
|CHL
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|AI, HFIB, HF8 and COAG
|-
|'''Measurement Uncertainty'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Lab Notes'''
|Two 2.7ml citrated (BLUE top) collection tubes are required. The samples are registered for an INR, APTT, Fibrinogen and FVIII and sendaway test – registration codes AI, HFIB, HF8 and COAG
|}

Tests:Intraossesous sample

2025-11-26T19:26:54Z

Glim:

{{DISPLAYTITLE: Intraosseous sample}}
[[Category:Tests]]
[[Category:Haematology]]
[[Category:Biochemistry]]

{|class="wikitable"
|'''Synonym(s)'''
|I.O sample, IO, Intraoss
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Sample Type'''
|Whole blood aspirate for CBC, Plasma or Serum for biochemistry tests
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|CBCD, FLUD
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Intraosseous samples are not suitable for full analyte testing:
Haematology - The only reportable analytes are: '''Haemoglobin''' and '''Haematocrit only''' (Special Correction Procedures SOP). No coagulation testing available.

Biochemistry - Do not put intraosseous samples through the Blood gas analyser as whole blood.

Run as Fluid Chemistry. The only reportable analytes are: '''Sodium, Chloride, Glucose, Calcium, Urea, Creatinine, Albumin, Total protein, and pH only.'''
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Intraossesous sample

2025-11-26T19:26:40Z

Glim:

{{DISPLAYTITLE: Intraosseous sample}}
[[Category:Tests]]
[[Category:Haematology]]
[[Category:Biochemistry]]

{|class="wikitable"
|'''Synonym(s)'''
|I.O sample, IO, Intraoss
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Sample Type'''
|Whole blood aspirate for CBC, Plasma or Serum for biochemistry tests
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|CBCD, FLUD
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Intraosseous samples are not suitable for full analyte testing:
Haematology - The only reportable analytes are: '''Haemoglobin''' and '''Haematocrit only''' (Special Correction Procedures SOP)No coagulation testing available.

Biochemistry - Do not put intraosseous samples through the Blood gas analyser as whole blood.

Run as Fluid Chemistry. The only reportable analytes are: '''Sodium, Chloride, Glucose, Calcium, Urea, Creatinine, Albumin, Total protein, and pH only.'''
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Intraossesous sample

2025-11-24T20:23:48Z

Glim:

{{DISPLAYTITLE: Intraosseous sample}}
[[Category:Tests]]
[[Category:Haematology]]
[[Category:Biochemistry]]

{|class="wikitable"
|'''Synonym(s)'''
|I.O sample
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Sample Type'''
|Whole blood aspirate for CBC, Plasma or Serum for biochemistry tests
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|CBCD, FLUD
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Intraosseous samples are not suitable for full analyte testing:
Haematology - The only reportable analytes are: Haemoglobin and Haematocrit only. No coagulation testing available.

Biochemistry - Do not put intraosseous samples through the Blood gas analyser as whole blood.

Run as Fluid Chemistry. The only reportable analytes are: Sodium, Chloride, Glucose, Calcium, Urea, Creatinine, Albumin, Total protein, and pH only.
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Intraossesous sample

2025-11-24T03:45:27Z

Glim:

{{DISPLAYTITLE: Intraosseous sample}}
[[Category:Tests]]
[[Category:Haematology]]
[[Category:Biochemistry]]

{|class="wikitable"
|'''Synonym(s)'''
|I.O sample
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Sample Type'''
|Whole blood aspirate for CBC, Plasma or Serum for biochemistry tests
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|CBCD, FLUD
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Intraosseous samples are not suitable for full analyte testing:
Haematology - The only reportable analytes are: Haemoglobin and Haematocrit only. No coagulation testing available.

Biochemistry - Run as Fluid Chemistry. The only reportable analytes are: Sodium, Chloride, Glucose, Calcium, Urea, Creatinine, Albumin, Total protein, and pH only.
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Intraossesous sample

2025-11-24T03:44:27Z

Glim: Haem and biochem tests

{{DISPLAYTITLE: Intraosseous sample}}
[[Category:Tests]]
[[Category:Haematology]]
[[Category:Biochemistry]]

{|class="wikitable"
|'''Synonym(s)'''
|I.O sample
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Sample Type'''
|Whole blood aspirate for CBC, Plasma or Serum for biochemistry tests
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|CBCD, FLUD
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Intraosseous samples are not suitable for full analyte testing:
Haematology - The only reportable analytes are: Haemoglobin and Haematocrit only. No coagulation testing available.
Biochemistry - Run as Fluid Chemistry. The only reportable analytes are: Sodium, Chloride, Glucose, Calcium, Urea, Creatinine, Albumin, Total protein, and pH only.
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Intraossesous sample

2025-11-24T03:25:18Z

Glim:

Tests:Intraossesous sample

2025-11-24T03:22:29Z

Glim:

{{DISPLAYTITLE: Intraosseous sample}
[[Category:Tests]]
[[Category:Haematology]]
[[Category:Biochemistry]]}| class="wikitable"
|'''Synonym(s)'''
|I.O sample
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Paediatric Specimen'''
|
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Intraossesous sample

2025-11-24T03:18:18Z

Glim: New test

{| class="wikitable"
|'''Synonym(s)'''
|I.O sample
|-
|'''Specimen'''
|1 x Lithium Heparin (green) tube, 1 x EDTA (purple) tube, Sealed Arterial Blood Gas Syringe
|-
|'''Paediatric Specimen'''
|
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Biochemistry ext. 2448, Haematology ext.2445
|-
|'''Registration Code'''
|
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|
|-
|'''Measurement Uncertainty'''
|N/A
|}

CBC Reference Ranges

2025-11-23T20:58:45Z

Glim: typo

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
'''*''' MCHC 13-15 years: Female 315-350 Male 318-353

'''Reticulocytes (x 109/L)'''

Adult 10 - 100

'''Platelet distribution width (PDW)'''

15.3 - 18.0

'''Mean platelet volume (MPV)'''

7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)

'''ESR mm/hr'''
{| class="wikitable"
!Male
!Normal range
|-
|<= 20 years
|<10 mm/hr
|-
|21 -50 years
|<20 mm/hr
|-
|>50 years
|<25 mm/hr
|}
{| class="wikitable"
!Female
!Normal range
|-
|<= 20 years
|<10 mm/hr
|-
|21 -50 years
|<25 mm/hr
|-
|51-65 years
|<30 mm/hr
|-
|>66 years
|<40 mm/hr
|}

Reviewed November 2025

CBC Reference Ranges

2025-11-23T20:58:24Z

Glim: ESR ranges

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
'''*''' MCHC 13-15 years: Female 315-350 Male 318-353

'''Reticulocytes (x 109/L)'''

Adult 10 - 100

'''Platelet distribution width (PDW)'''

15.3 - 18.0

'''Mean platelet volume (MPV)'''

7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)

'''ESR mm/hr'''
{| class="wikitable"
!Male
!Normal range
|-
|<= 20 years
|<10 mm/hr
|-
|21 -50 years
|<20 mm/hr
|-
|>50 years ago
|<25 mm/hr
|}
{| class="wikitable"
!Female
!Normal range
|-
|<= 20 years
|<10 mm/hr
|-
|21 -50 years
|<25 mm/hr
|-
|51-65 years
|<30 mm/hr
|-
|>66 years
|<40 mm/hr
|}

Reviewed November 2025

Haematology Department information

2025-11-07T03:02:47Z

Glim: Malaria - clarified LAMP PCR, and removed thick film reference

== Routine Haematology (CBC, FBC, Blood count) ==
Specimen required: EDTA anticoagulated whole blood (purple or lavender top tube). Specimen must be well mixed and free from clots.

Automated analysis will provide:

Haemoglobin

Haematocrit

MCV

MCH

Platelets

WBC and differential

These results will be made available in Clinical Portal as soon as they are available.

Results from automated analysis may appear as unauthorised in Clinical Portal and are '''subject to change.''' These results will update to authorised when reviewed and released by Scientist staff - this may not be until the next day. Amended results that have changed by a clinically significant amount will be communicated by phone. Community results for General Practice will be reported electronically (by HL7 Healthlink) when the results are authorised, this may not be until the next working day.

If results indicate, or if specifically requested, the blood film is examined and a comment made. '''Note this may not be until the next day, or longer on weekends and public holidays.''' If not available immediately, blood film review can be arranged by phone at any time. Please contact the laboratory to arrange this.

=== Paediatric ===
Capillary or venous blood collected into EDTA (purple or lavender top) Microtainers (0.5 ml) can be used. Successful analysis on volumes below 250ul cannot be guaranteed but analysis may be possible below this.

=== Reticulocyte count ===
Performed on request or at the discretion of Haematology staff based on the CBC/Blood Film results. Analysis is automated and performed on the same specimen as the CBC so no additional samples are required.

== ESR ==
ESR requests are vetted and only performed for appropriate clinical indications. Clinical details must be provided. A minimum of 1.5ml whole blood is required for this assay, microtainer collects are therefore not appropriate.

=== Guideline on ESR acceptance criteria ===
The recommended marker for infection/inflammation is CRP. The lab will therefore only perform ESR testing for specific clinical indications where it has been shown to be of clinical value. ESR requests will only be processed if one of the following clinical details is provided and clearly marked on the request form:

[[ESR Indications for testing|Click here for ESR Indications for testing]]

== Bone Marrow examination ==
Contact with Clinical Haematology (Palmerston North) is required before ordering Bone Marrow trephine and aspirate collection. Haematology staff must be present at the collection procedure to prepare the required samples, and this '''must be pre-arranged with the laboratory''' as availability of staff cannot always be guaranteed.

Analysis is not carried out on site but referred to Clinical Haematology (Palmerston North) and other reference labs for specialist testing as appropriate.

== Coagulation Tests ==
Collection & Specimen required:

· Adults: 2.7 ml Sodium Citrate (Blue top tube)

· Paediatric: 1.8 ml Sodium Citrate (Blue top tube)

Samples must be thoroughly mixed by inversion and be filled to the marked fill level on the tube. Samples must be free from clots and must not be grossly haemolysed or lipaemic to be suitable for analysis. Please refer to chart below for guidance on fill volumes, tubes filled below the minimum fill indicator may not be acceptable for analysis. Under or overfilled tubes may be rejected and a repeat specimen requested.

'''Please supply sufficient clinical information to ensure the appropriate tests are performed, including any anticoagulants that the patient is receiving.'''

=== Coagulation screen ===
[[File:Citrate.png|thumb|Click to enlarge picture]]
A routine coagulation screen will include an INR & APTT only. Fibrinogen and TCT will be performed if specifically requested or at the discretion of Haematology staff for further investigation as required.

D-Dimer, and Factor Assays require one full Blue top

=== Investigation of coagulation disorders ===
Unexplained abnormalities in coagulations screens will be investigated under the direction of the Head of Department. If a bleeding disorder is suspected, please phone the laboratory for advice on further testing.

=== Factor VIII ===
Routine Factor VIII assays are batched and performed weekly on Thursday. If this assay is requested urgently outside of 0800hrs to 2000hrs Monday to Friday, and on public holidays, a Haematology lab staff member will be called in to perform this assay. Laboratory staff may contact the requesting Doctor to confirm that the call back is required.

== Thrombophilia screen ==

6 full 2.7ml blue tops and 5ml in a red top are required.

Tests included in a thrombophilia screen:

Coagulation screen (INR, APTT, Fibrinogen and TCT)

Protein C and S

Antithrombin III (ATIII)

Activated Protein C Resistance (APCR)

Lupus Anticoagulant screen (LA)

Anticardiolipin antibodies (ACA)

Requests for thrombophilia testing are vetted and will only be performed for appropriate clinical indications as per below.

=== Guideline on Thrombophilia Screen acceptance criteria ===

==== When screening is indicated: ====
· Early age of onset <45 years

· Familial history of venous thromboembolism (VTE) with more than two other symptomatic 1st degree family members

· Thrombosis after trivial provocation, age <45 years with symptomatic 1st degree family member

· Intrauterine death at >20 weeks gestation

· Stillbirth at >20 weeks

· Neonatal purpura fulminans '''(Protein C and S only)'''

· Warfarin-induced skin necrosis '''(Protein C and S only – patient cannot be on warfarin)'''

· Association of thrombosis and fetal losses '''(Lupus anticoagulant only)'''

· Arterial thrombosis '''(Lupus anticoagulant only)'''

==== When screening is not indicated: ====
· Commencement of oral contraceptive/hormone replacement therapy.

· General obstetrics – those clinically at risk should receive thromboprophylaxis regardless of thrombophilia screening

· Cancer patient screening

· Recurrent idiopathic thrombosis - by definition this is an indication for prolonged secondary prophylaxis

· Age of onset >45 years

'''Note:''' The existence of underlying conditions, drugs and treatment need to be considered as these may be the causative agents of clot formation.

== Malaria ==
Please include clinical details on the form including recent travel locations, previous history of malaria and which type if positive.

Malaria screen is performed by LAMP PCR, and if positive followed up with immunochromatography (ICT) for malarial antigens, and thin film examination for species identification.

The required sample type is EDTA whole blood and can be performed from the same tube as the CBC.

== Reference ranges ==
Age and sex adjusted reference ranges are issued as part of the standard report for all haematology testing. [[CBC Reference Ranges|Click here for a detailed table.]]

Contact the Haematology Department for advice on interpretation of Neonatal and paediatric coagulation results (to 16 years).

== Contacts ==
Haematology Laboratory

Phone 06 878 1308 Ext 2445

'''Grace Lim'''

Head of Department

(06) 878 1647 or internal ext 6249

== Consultant Haematologist Clinical cover ==
Health New Zealand - Mid-Central Hospital provides a 24 hour specialist cover for clinicians and laboratory staff.

The following Haematologists can be contacted at (06) 350 8550 option 4

Dr Bart Baker

Dr Allanah Kilfoyle

Dr Matt Stephens

Last reviewed 07/11/2025 by Grace Lim

Coagulation reference ranges

2025-11-07T02:58:21Z

Glim:

{| class="wikitable"
|'''Parameter'''
|'''Units'''
|'''Normal range'''
|'''Therapeutic range'''
|-
|INR
|Ratio
|0.8 - 1.2
|2.0 - 3.0*
|-
|APTT
|Seconds
|24-38
|50 - 85 secs
|-
|FIBRINOGEN
|g/L
|1.5-4.0
|N/A
|-
|TCT
|Seconds
|15 - 21
|N/A
|-
|D DIMER
|ug/L
|<50 yrs 500
51-60yrs 600

61-70yrs 700

71-80yrs 800

>80yrs 900
|N/A
|-
|FVIII
|iu/dl
|50 - 150
|N/A
|}
<nowiki>*</nowiki>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.

Reviewed August 2025

Coagulation reference ranges

2025-11-07T02:57:43Z

Glim: Updated D Dimer ranges to age-specific

{| class="wikitable"
|'''Parameter'''
|'''Units'''
|'''Normal range'''
|'''Therapeutic range'''
|-
|INR
|Ratio
|0.8 - 1.2
|2.0 - 3.0*
|-
|APTT
|Seconds
|24-38
|50 - 85 secs
|-
|FIBRINOGEN
|g/L
|1.5-4.0
|N/A
|-
|TCT
|Seconds
|15 - 21
|N/A
|-
|D DIMER
|ug/L
|<50 yrs 500
51-60yrs 600
61-70yrs 700
71-80yrs 800
>80yrs 900
|N/A
|-
|FVIII
|iu/dl
|50 - 150
|N/A
|}
<nowiki>*</nowiki>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.

Reviewed August 2025

Haematology Critical Ranges

2025-11-07T02:50:33Z

Glim: D Dimer, removed lower limit - based on age now.

== '''Hospital patients critical ranges (includes out-patients)''' ==
{| class="wikitable"
|'''Test'''
|'''Reporting units'''
|'''Lower limit'''
|'''Upper limit'''
|-
|WBC
|x 109/L
|N/A
|50
|-
|Hb
|g/L
|70
|
|-
|Platelets
|x 109/L
|50
|1000
|-
|Neutrophils
|x 109/L
|0.5
|30
|-
|INR
|
|
|2.0 (if not on anticoagulants)
|-
|
|
|
|5.0 (if on warfarin and fax results to pharmacy)
|-
|APTT
|secs
|
|50 (if not on anticoagulants)
|-
|
|
|
|150 (if on heparin)
|-
|Fibrinogen
|g/L
|1.0
|
|}

== '''Community patients critical ranges''' ==
{| class="wikitable"
|'''Test'''
|'''Reporting units'''
|'''Lower limit'''
|'''Upper limit'''
|-
|WBC
|x 109/L
|2.0
|50
|-
|Hb
|g/L
|80
|
|-
|Platelets
|x 109/L
|90
|1000
|-
|Neutrophils
|x 109/L
|0.5
|25
|-
|INR
|
|
|5.0
|-
|Fibrinogen
|g/L
|1.0
|
|-
|D-Dimers
|μg/L
|
|Age Cut-off
''≤ 50 500 ug/L''

''51-60 600 ug/L''

''61-70 700 ug/L''

''71-80 800 ug/L''

''>80 900 ug/L''
|-
|Malaria
|
| colspan="2" |All malaria results to be phoned and faxed
|}
<nowiki>*</nowiki>Also known as Panic Ranges

Reviewed August 2025

CBC Reference Ranges

2025-11-07T02:47:22Z

Glim:

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
'''*''' MCHC 13-15 years: Female 315-350 Male 318-353

'''Reticulocytes (x 109/L)'''

Adult 10 - 100

'''Platelet distribution width (PDW)'''

15.3 - 18.0

'''Mean platelet volume (MPV)'''

7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed December 2024

Haematology Department information

2025-04-07T03:25:57Z

Glim: /* Consultant Haematologist Clinical cover */

== Routine Haematology (CBC, FBC, Blood count) ==
Specimen required: EDTA anticoagulated whole blood (purple or lavender top tube). Specimen must be well mixed and free from clots.

Automated analysis will provide:

Haemoglobin

Haematocrit

MCV

MCH

Platelets

WBC and differential

These results will be made available in Clinical Portal as soon as they are available.

Results from automated analysis may appear as unauthorised in Clinical Portal and are '''subject to change.''' These results will update to authorised when reviewed and released by Scientist staff - this may not be until the next day. Amended results that have changed by a clinically significant amount will be communicated by phone. Community results for General Practice will be reported electronically (by HL7 Healthlink) when the results are authorised, this may not be until the next working day.

If results indicate, or if specifically requested, the blood film is examined and a comment made. '''Note this may not be until the next day, or longer on weekends and public holidays.''' If not available immediately, blood film review can be arranged by phone at any time. Please contact the laboratory to arrange this.

=== Paediatric ===
Capillary or venous blood collected into EDTA (purple or lavender top) Microtainers (0.5 ml) can be used. Successful analysis on volumes below 250ul cannot be guaranteed but analysis may be possible below this.

=== Reticulocyte count ===
Performed on request or at the discretion of Haematology staff based on the CBC/Blood Film results. Analysis is automated and performed on the same specimen as the CBC so no additional samples are required.

== ESR ==
ESR requests are vetted and only performed for appropriate clinical indications. Clinical details must be provided. A minimum of 1.5ml whole blood is required for this assay, microtainer collects are therefore not appropriate.

=== Guideline on ESR acceptance criteria ===
The recommended marker for infection/inflammation is CRP. The lab will therefore only perform ESR testing for specific clinical indications where it has been shown to be of clinical value. ESR requests will only be processed if one of the following clinical details is provided and clearly marked on the request form:

[[ESR Indications for testing|Click here for ESR Indications for testing]]

== Bone Marrow examination ==
Contact with Clinical Haematology (Palmerston North) is required before ordering Bone Marrow trephine and aspirate collection. Haematology staff must be present at the collection procedure to prepare the required samples, and this '''must be pre-arranged with the laboratory''' as availability of staff cannot always be guaranteed.

Analysis is not carried out on site but referred to Clinical Haematology (Palmerston North) and other reference labs for specialist testing as appropriate.

== Coagulation Tests ==
Collection & Specimen required:

· Adults: 2.7 ml Sodium Citrate (Blue top tube)

· Paediatric: 1.8 ml Sodium Citrate (Blue top tube)

Samples must be thoroughly mixed by inversion and be filled to the marked fill level on the tube. Samples must be free from clots and must not be grossly haemolysed or lipaemic to be suitable for analysis. Please refer to chart below for guidance on fill volumes, tubes filled below the minimum fill indicator may not be acceptable for analysis. Under or overfilled tubes may be rejected and a repeat specimen requested.

'''Please supply sufficient clinical information to ensure the appropriate tests are performed, including any anticoagulants that the patient is receiving.'''

=== Coagulation screen ===
[[File:Citrate.png|thumb|Click to enlarge picture]]
A routine coagulation screen will include an INR & APTT only. Fibrinogen and TCT will be performed if specifically requested or at the discretion of Haematology staff for further investigation as required.

D-Dimer, and Factor Assays require one full Blue top

=== Investigation of coagulation disorders ===
Unexplained abnormalities in coagulations screens will be investigated under the direction of the Head of Department. If a bleeding disorder is suspected, please phone the laboratory for advice on further testing.

=== Factor VIII ===
Routine Factor VIII assays are batched and performed weekly on Thursday. If this assay is requested urgently outside of 0800hrs to 2000hrs Monday to Friday, and on public holidays, a Haematology lab staff member will be called in to perform this assay. Laboratory staff may contact the requesting Doctor to confirm that the call back is required.

== Thrombophilia screen ==

6 full 2.7ml blue tops and 5ml in a red top are required.

Tests included in a thrombophilia screen:

Coagulation screen (INR, APTT, Fibrinogen and TCT)

Protein C and S

Antithrombin III (ATIII)

Activated Protein C Resistance (APCR)

Lupus Anticoagulant screen (LA)

Anticardiolipin antibodies (ACA)

Requests for thrombophilia testing are vetted and will only be performed for appropriate clinical indications as per below.

=== Guideline on Thrombophilia Screen acceptance criteria ===

==== When screening is indicated: ====
· Early age of onset <45 years

· Familial history of venous thromboembolism (VTE) with more than two other symptomatic 1st degree family members

· Thrombosis after trivial provocation, age <45 years with symptomatic 1st degree family member

· Intrauterine death at >20 weeks gestation

· Stillbirth at >20 weeks

· Neonatal purpura fulminans '''(Protein C and S only)'''

· Warfarin-induced skin necrosis '''(Protein C and S only – patient cannot be on warfarin)'''

· Association of thrombosis and fetal losses '''(Lupus anticoagulant only)'''

· Arterial thrombosis '''(Lupus anticoagulant only)'''

==== When screening is not indicated: ====
· Commencement of oral contraceptive/hormone replacement therapy.

· General obstetrics – those clinically at risk should receive thromboprophylaxis regardless of thrombophilia screening

· Cancer patient screening

· Recurrent idiopathic thrombosis - by definition this is an indication for prolonged secondary prophylaxis

· Age of onset >45 years

'''Note:''' The existence of underlying conditions, drugs and treatment need to be considered as these may be the causative agents of clot formation.

== Malaria ==
Please include clinical details on the form including recent travel locations, previous history of malaria and which type if positive.

Malaria screen is performed by PCR, and if positive followed up with immunochromatography (ICT) for malarial antigens and thick and thin film examination.

The required sample type is EDTA whole blood and can be performed from the same tube as the CBC.

== Reference ranges ==
Age and sex adjusted reference ranges are issued as part of the standard report for all haematology testing. [[CBC Reference Ranges|Click here for a detailed table.]]

Contact the Haematology Department for advice on interpretation of Neonatal and paediatric coagulation results (to 16 years).

== Contacts ==
Haematology Laboratory

Phone 06 878 1308 Ext 2445

'''Grace Lim'''

Head of Department

(06) 878 1647 or internal ext 6249

== Consultant Haematologist Clinical cover ==
Health New Zealand - Mid-Central Hospital provides a 24 hour specialist cover for clinicians and laboratory staff.

The following Haematologists can be contacted at (06) 350 8550 option 4

Dr Bart Baker

Dr Allanah Kilfoyle

Dr Matt Stephens

Last reviewed 07/04/2025 by Grace Lim

Tests:Myeloma Screen

2025-01-29T03:48:29Z

Glim: CBCD validity

{{DISPLAYTITLE:Myeloma Screen}}

[[Category:Tests]]
[[Category:Biochemistry]]
[[Category:Haematology]]
[[Category:Preanalytical]]
{| class="wikitable"
|'''Synonym(s)'''
|Myeloma
|-
|'''Tube/Container Type'''
|4 mL green top or gold top and 4 mL purple top - Serum sample required for SPEP sendaway (SCL)
|-
|'''''
|0.5 mL Paediatric brown, yellow, or green top and 0.5 purple top - Serum sample required for SPEP sendaway (SCL)
|-
|'''Sample Type'''
|EDTA whole blood for CBC, plasma or serum for biochemistry and serum for SPEP
|-
|'''Registration Code'''
|CBCD, PTP, PALB, IMMG, PCA, PCRN and SCL
|-
|'''Aliquot Instructions'''
|Plasma or Serum for biochemistry tests, Whole blood EDTA for CBC, Serum for SPEP sendaway (SCL)
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC, 300 uLfor SPEP sendaway (SCL)
|-
|'''Add-on conditions'''
|CBCD & blood film 24 hours @ 4°C
|-
|'''Test Availability'''
|N/A
|-
|'''Turnaround Time'''
|N/A
|-
|'''Where analysed'''
|Hastings and External Laboratory
|-
|'''Department'''
|Specimen Services ext. 2452, Biochemistry ext. 2448 and Haematology ext.2445
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Copy of form to Haematology to ensure Film performed
|-
|'''Measurement Uncertainty'''
|Available upon request
|}

Tests:Activated Partial Thromboplastin Time

2025-01-20T01:16:12Z

Glim: APTT 1+1

{{DISPLAYTITLE:Activated Partial Thromboplastin Time (APTT)}}
{| class="wikitable"
|-
|'''Synonym(s)'''
|APTT, PTT
|-
|'''Specimen'''
|2.7 mL Sodium Citrate (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|1.8 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volumes'''
|Citrate tube must be FULL.
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|HPTT
|-
|'''Deletion Code'''
|7171
|-
|'''Useful Information'''
|Samples that will take longer than 4 hours to arrive at the Hastings Laboratory should be separated and frozen for transport.
APTT 1+1 correction studies (registration code: HCOR) are performed by Haematology staff.
After hours: separate and freeze citrate plasma, place sample in Haematology drawer of -30 degree Biochemistry freezer.
|-
|'''Measurement Uncertainty'''
|Available upon request
|}
[[Category:Tests]]
[[Category:Haematology]]

CBC Reference Ranges

2024-12-19T19:25:12Z

Glim: Retics range amended. LIS job completed 18/12/24

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
'''*''' MCHC 13-15 years: Female 315-350 Male 318-353

'''Reticulocytes (x 109/L)'''

Adult 10 - 100

'''Platelet distribution width (PDW)'''

15.3 - 18.0

'''Mean platelet volume (MPV)'''

7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed June 2024

CBC Reference Ranges

2024-08-19T23:46:05Z

Glim:

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
'''*''' MCHC 13-15 years: Female 315-350 Male 318-353

'''Reticulocytes (x 109/L)'''

Adult 20 - 100

'''Platelet distribution width (PDW)'''

15.3 - 18.0

'''Mean platelet volume (MPV)'''

7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed June 2024

CBC Reference Ranges

2024-08-19T23:42:44Z

Glim:

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
<nowiki>*</nowiki> MCHC 13-15 years Female 315-350 Male 318-353

Reticulocytes (x 109/L)

Adult 20 - 100

PDW 15.3 - 18.0

MPV 7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed June 2024

Tests:Von Willebrand Screen

2024-08-14T03:53:29Z

Glim:

{{DISPLAYTITLE:Von Willebrand Screen}}

[[Category:Tests]]
[[Category:Haematology]]
[[Category:CHL]]
{| class="wikitable"
|'''Synonym(s)'''
|VWD, Von Willebrands disease, vWF, vWF:Ag; vWF:RCo; von Willebrand Panel; Ristocetin Cofactor; vWF:RCof; Collagen binding; vWF:CBA
|-
|'''Specimen'''
|2 x 2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tubes must be FULL
Separated plasma - 2mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Turnaround Time'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Where analysed'''
|CHL
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|AI, HFIB, HF8 and COAG
|-
|'''Measurement Uncertainty'''
|Referred test to CHL - [https://www.chl.co.nz/test/von-willebrand-screen/ refer to CHL website.]
|-
|'''Lab Notes'''
|Two 2.7ml citrated (BLUE top) collection tubes are required. The samples are registered for an INR, APTT, Fibrinogen and FVIII and sendaway test – registration codes AI, HFIB, HF8 and COAG
|}

Tests:Myeloma Screen

2024-08-14T03:52:34Z

Glim:

{{DISPLAYTITLE:Myeloma Screen}}

[[Category:Tests]]
[[Category:Biochemistry]]
[[Category:Haematology]]
[[Category:Preanalytical]]
{| class="wikitable"
|'''Synonym(s)'''
|Myeloma
|-
|'''Specimen'''
|4 mL Lithium Heparin (green top) or SST (gold top) and 4 mL EDTA (purple top) - Serum sample required for SPEP sendaway (SCL)
|-
|'''Paediatric Specimen'''
|0.5 mL Brown, yellow, or green top and 0.5 EDTA - Serum sample required for SPEP sendaway (SCL)
|-
|'''Aliquot Instructions'''
|Plasma or Serum for biochemistry tests, Whole blood EDTA for CBC, Serum for SPEP sendaway (SCL)
|-
|'''Minimum Volumes'''
|200 uL for Biochemistry, 250 uL for CBC, 300 uLfor SPEP sendaway (SCL)
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|N/A
|-
|'''Turnaround Time'''
|N/A
|-
|'''Where analysed'''
|Hastings and External Laboratory
|-
|'''Department'''
|Specimen Services ext. 2452, Biochemistry ext. 2448 and Haematology ext.2445
|-
|'''Registration Code'''
|CBCD, PTP, PALB, IMMG, PCA, PCRN and SCL
|-
|'''Deletion Code'''
|N/A
|-
|'''Useful Information'''
|Copy of form to Haematology to ensure Film performed
|-
|'''Measurement Uncertainty'''
|Available upon request
|}

Tests:Malaria

2024-08-14T03:51:58Z

Glim:

{{DISPLAYTITLE:Malaria}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|Malarial parasites, Malaria screen, Malaria microscopy, Malaria PCR, Malaria RDT
|-
|'''Specimen'''
|4 mL EDTA (Purple top)
|-
|'''Paediatric Specimen'''
|0.5 mL EDTA (Purple top) + 0.5 mL Plain
|-
|'''Minimum Volume'''
|250uL
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|HMAL
|-
|'''Deletion Code'''
|9938
|-
|'''Useful Information'''
|[https://www.cdc.gov/malaria/index.html Click here]
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Kleihauer

2024-08-14T03:50:05Z

Glim:

{{DISPLAYTITLE:Kleihauer}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|foetal cell staining, maternal foetal cell screen, foetal-maternal bleed test, foetal maternal hemorrhage (FMH), acid elution
|-
|'''Specimen'''
|4 mL EDTA (Purple top)
|-
|'''Paediatric Specimen'''
|0.5 mL EDTA (Purple top)
|-
|'''Minimum Volume'''
|250uL
|-
|'''Add-on conditions'''
|24 hours @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|KLEI
|-
|'''Deletion Code'''
|1963
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:International Normalised Ratio

2024-08-14T03:49:50Z

Glim:

{{DISPLAYTITLE: International Normalised Ratio}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|INR, Prothrombin Time, PT, PR
|-
|'''Specimen'''
|2.7 mL Sodium Citrate (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|1.8 mL Sodium Citrate (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tube must be FULL
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|24 hours @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|HINR
|-
|'''Deletion Code'''
|7172
|-
|'''Measurement Uncertainty'''
|Available upon request
|}

Tests:Infectious Mononucleosis Screen

2024-08-14T03:49:29Z

Glim:

{{DISPLAYTITLE:Infectious Mononucleosis Screen}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|IM Screen, IM, IMST, Glandular Fever Screen, GF Screen, monospot Paul Bunnell, heterophile antibodies
|-
|'''Specimen'''
|4 mL EDTA(Purple top), Lithium heparin (Green top), SST (Gold top), Sodium citrate (Blue top)
|-
|'''Paediatric Specimen'''
|0.5 mL EDTA (Purple top), 0.5 mL Lithium heparin (green), 0.5 mL SST (Gold or brown top)
|-
|'''Minimum Volume'''
|250uL (whole blood, serum, plasma)
|-
|'''Add-on conditions'''
|3 days @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|IM
|-
|'''Deletion Code'''
|1017
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:DIC Screen

2024-08-14T03:19:21Z

Glim:

{{DISPLAYTITLE:DIC Screen}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|DIC
|-
|'''Specimen'''
|2.8 mL Sodium Citrate ONLY (Blue top - Must be FULL) and 4 mL EDTA (purple top)
|-
|'''Paediatric Specimen'''
|1.8 mL Sodium Citrate ONLY (Blue top - Must be FULL) and 0.5 mL EDTA (purple top)
|-
|'''Minimum Volumes'''
|250uL for CBC, Citrate tube must be FULL
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology (06) 878 1308 ext.2445
|-
|'''Registration Code'''
|AI, HFIB, HDD and CBCD
|-
|'''Deletion Code'''
|N/A
|-
|'''Measurement Uncertainty'''
|Available upon request
|}

Tests:D-Dimer

2024-08-14T03:19:01Z

Glim:

{{DISPLAYTITLE:D-Dimer}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|DD, FDP, DIC Screen, XDP, fibrin degradation products
|-
|'''Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|1.8 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volumes'''
|Citrate tube must be FULL
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|8 Hours
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|HDD
|-
|'''Deletion Code'''
|7178
|-
|'''Useful Information'''
|Samples that will take longer than 8 hours to arrive at the Hastings Laboratory should be separated and frozen for transport
|-
|'''Measurement Uncertainty'''
|Available upon request
|}

Tests:Complete Blood Count

2024-08-14T03:18:37Z

Glim:

{{DISPLAYTITLE:Complete Blood Count}}
{| class="wikitable"
|'''Synonym(s)'''
|CBC, FBC, Full Blood Count, FBP, Hb, Haemoglobin, WBC, WCC, PCV, HCT, Plt, MCV, MCH, white cells
|-
|'''Specimen'''
|4 mL EDTA ONLY (Purple top)
|-
|'''Paediatric Specimen'''
|0.5 mL EDTA ONLY (Purple top)
|-
|'''Minimum Volume'''
|250uL
|-
|'''Add-on conditions'''
|24 hours @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|CBCD
|-
|'''Deletion Code'''
|1000
|-
|'''Measurement Uncertainty'''
|Available upon request
|-
|'''Reference Ranges'''
|[[CBC Reference Ranges|Click Here]]
|}
[[Category:Tests]]
[[Category:Haematology]]

Tests:ESR

2024-08-14T03:16:51Z

Glim:

{{DISPLAYTITLE:ESR}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|erythrocyte sedimentation rate, Sed Rate
|-
|'''Specimen'''
|4 mL EDTA ONLY(Purple top)
|-
|'''Paediatric Specimen'''
|4 mL EDTA ONLY (Purple top)
|-
|'''Minimum Volume'''
|1.5mL
|-
|'''Add-on conditions'''
|12 hours @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours. Please supply relevant clinical information.
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|ESR
|-
|'''Deletion Code'''
|1015
|-
|'''Useful Information'''
|Samples are vetted for suitability before being processed. [https://hawkesbaylabmanual.co.nz/wiki/index.php/ESR_Indications_for_testing Click here for acceptance criteria]
|-
|'''Measurement Uncertainty'''
|Available upon request
|}

Haematology Critical Ranges

2024-07-09T21:33:36Z

Glim:

== '''Hospital patients critical ranges (includes out-patients)''' ==
{| class="wikitable"
|'''Test'''
|'''Reporting units'''
|'''Lower limit'''
|'''Upper limit'''
|-
|WBC
|x 109/L
|N/A
|50
|-
|Hb
|g/L
|70
|
|-
|Platelets
|x 109/L
|50
|1000
|-
|Neutrophils
|x 109/L
|0.5
|30
|-
|INR
|
|
|2.0 (if not on anticoagulants)
|-
|
|
|
|5.0 (if on warfarin and fax results to pharmacy)
|-
|APTT
|secs
|
|50 (if not on anticoagulants)
|-
|
|
|
|150 (if on heparin)
|-
|Fibrinogen
|g/L
|1.0
|
|}

== '''Community patients critical ranges''' ==
{| class="wikitable"
|'''Test'''
|'''Reporting units'''
|'''Lower limit'''
|'''Upper limit'''
|-
|WBC
|x 109/L
|2.0
|50
|-
|Hb
|g/L
|80
|
|-
|Platelets
|x 109/L
|90
|1000
|-
|Neutrophils
|x 109/L
|0.5
|25
|-
|INR
|
|
|5.0
|-
|Fibrinogen
|g/L
|1.0
|
|-
|D-Dimers
|μg/L
|less than 500
(email/fax only)
|Age
''≤ 50 500 ug/L''

''51-60 600 ug/L''

''61-70 700 ug/L''

''71-80 800 ug/L''

''>80 900 ug/L''
|-
|Malaria
|
| colspan="2" |All malaria results to be phoned and faxed
|}
<nowiki>*</nowiki>Also known as Panic Ranges

Reviewed November 2023

Coagulation reference ranges

2024-07-09T21:33:14Z

Glim:

{| class="wikitable"
|'''Parameter'''
|'''Units'''
|'''Normal range'''
|'''Therapeutic range'''
|-
|INR
|Ratio
|0.8 - 1.2
|2.0 - 3.0*
|-
|APTT
|Seconds
|24-38
|50 - 85 secs
|-
|FIBRINOGEN
|g/L
|1.5-4.0
|N/A
|-
|TCT
|Seconds
|15 - 21
|N/A
|-
|D DIMER
|ug/L
|< 500
|N/A
|-
|FVIII
|iu/dl
|50 - 150
|N/A
|}
<nowiki>*</nowiki>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.

Reviewed June 2024

CBC Reference Ranges

2024-07-09T21:32:06Z

Glim:

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
<nowiki>*</nowiki> MCHC 13-15 years Female 315-350 Male 318-353

Reticulocytes (x 109/L)

Adult 15 - 100

PDW 15.3 - 18.0

MPV 7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed June 2024

CBC Reference Ranges

2024-07-09T21:31:52Z

Glim:

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
<nowiki>*</nowiki> MCHC 13-15 years Female 315-350 Male 318-353

Reticulocytes (x 109/L)

Adult 15 - 100

PDW 15.3 - 18.0

MPV 7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed June 2025

Haematology Department information

2024-07-09T21:17:29Z

Glim: Grammer and spacing. Health NZ for Mid Central hospital

== Routine Haematology (CBC, FBC, Blood count) ==
Specimen required: EDTA anticoagulated whole blood (purple or lavender top tube). Specimen must be well mixed and free from clots.

Automated analysis will provide:

Haemoglobin

Haematocrit

MCV

MCH

Platelets

WBC and differential

These results will be made available in Clinical Portal as soon as they are available.

Results from automated analysis may appear as unauthorised in Clinical Portal and are '''subject to change.''' These results will update to authorised when reviewed and released by Scientist staff - this may not be until the next day. Amended results that have changed by a clinically significant amount will be communicated by phone. Community results for General Practice will be reported electronically (by HL7 Healthlink) when the results are authorised, this may not be until the next working day.

If results indicate, or if specifically requested, the blood film is examined and a comment made. '''Note this may not be until the next day, or longer on weekends and public holidays.''' If not available immediately, blood film review can be arranged by phone at any time. Please contact the laboratory to arrange this.

=== Paediatric ===
Capillary or venous blood collected into EDTA (purple or lavender top) Microtainers (0.5 ml) can be used. Successful analysis on volumes below 250ul cannot be guaranteed but analysis may be possible below this.

=== Reticulocyte count ===
Performed on request or at the discretion of Haematology staff based on the CBC/Blood Film results. Analysis is automated and performed on the same specimen as the CBC so no additional samples are required.

== ESR ==
ESR requests are vetted and only performed for appropriate clinical indications. Clinical details must be provided. A minimum of 1.5ml whole blood is required for this assay, microtainer collects are therefore not appropriate.

=== Guideline on ESR acceptance criteria ===
The recommended marker for infection/inflammation is CRP. The lab will therefore only perform ESR testing for specific clinical indications where it has been shown to be of clinical value. ESR requests will only be processed if one of the following clinical details is provided and clearly marked on the request form:

[[ESR Indications for testing|Click here for ESR Indications for testing]]

== Bone Marrow examination ==
Contact with Clinical Haematology (Palmerston North) is required before ordering Bone Marrow trephine and aspirate collection. Haematology staff must be present at the collection procedure to prepare the required samples, and this '''must be pre-arranged with the laboratory''' as availability of staff cannot always be guaranteed.

Analysis is not carried out on site but referred to Clinical Haematology (Palmerston North) and other reference labs for specialist testing as appropriate.

== Coagulation Tests ==
Collection & Specimen required:

· Adults: 2.7 ml Sodium Citrate (Blue top tube)

· Paediatric: 1.8 ml Sodium Citrate (Blue top tube)

Samples must be thoroughly mixed by inversion and be filled to the marked fill level on the tube. Samples must be free from clots and must not be grossly haemolysed or lipaemic to be suitable for analysis. Please refer to chart below for guidance on fill volumes, tubes filled below the minimum fill indicator may not be acceptable for analysis. Under or overfilled tubes may be rejected and a repeat specimen requested.

'''Please supply sufficient clinical information to ensure the appropriate tests are performed, including any anticoagulants that the patient is receiving.'''

=== Coagulation screen ===
[[File:Citrate.png|thumb|Click to enlarge picture]]
A routine coagulation screen will include an INR & APTT only. Fibrinogen and TCT will be performed if specifically requested or at the discretion of Haematology staff for further investigation as required.

D-Dimer, and Factor Assays require one full Blue top

=== Investigation of coagulation disorders ===
Unexplained abnormalities in coagulations screens will be investigated under the direction of the Head of Department. If a bleeding disorder is suspected, please phone the laboratory for advice on further testing.

=== Factor VIII ===
Routine Factor VIII assays are batched and performed weekly on Thursday. If this assay is requested urgently outside of 0800hrs to 2000hrs Monday to Friday, and on public holidays, a Haematology lab staff member will be called in to perform this assay. Laboratory staff may contact the requesting Doctor to confirm that the call back is required.

== Thrombophilia screen ==

6 full 2.7ml blue tops and 5ml in a red top are required.

Tests included in a thrombophilia screen:

Coagulation screen (INR, APTT, Fibrinogen and TCT)

Protein C and S

Antithrombin III (ATIII)

Activated Protein C Resistance (APCR)

Lupus Anticoagulant screen (LA)

Anticardiolipin antibodies (ACA)

Requests for thrombophilia testing are vetted and will only be performed for appropriate clinical indications as per below.

=== Guideline on Thrombophilia Screen acceptance criteria ===

==== When screening is indicated: ====
· Early age of onset <45 years

· Familial history of venous thromboembolism (VTE) with more than two other symptomatic 1st degree family members

· Thrombosis after trivial provocation, age <45 years with symptomatic 1st degree family member

· Intrauterine death at >20 weeks gestation

· Stillbirth at >20 weeks

· Neonatal purpura fulminans '''(Protein C and S only)'''

· Warfarin-induced skin necrosis '''(Protein C and S only – patient cannot be on warfarin)'''

· Association of thrombosis and fetal losses '''(Lupus anticoagulant only)'''

· Arterial thrombosis '''(Lupus anticoagulant only)'''

==== When screening is not indicated: ====
· Commencement of oral contraceptive/hormone replacement therapy.

· General obstetrics – those clinically at risk should receive thromboprophylaxis regardless of thrombophilia screening

· Cancer patient screening

· Recurrent idiopathic thrombosis - by definition this is an indication for prolonged secondary prophylaxis

· Age of onset >45 years

'''Note:''' The existence of underlying conditions, drugs and treatment need to be considered as these may be the causative agents of clot formation.

== Malaria ==
Please include clinical details on the form including recent travel locations, previous history of malaria and which type if positive.

Malaria screen is performed by PCR, and if positive followed up with immunochromatography (ICT) for malarial antigens and thick and thin film examination.

The required sample type is EDTA whole blood and can be performed from the same tube as the CBC.

== Reference ranges ==
Age and sex adjusted reference ranges are issued as part of the standard report for all haematology testing. [[CBC Reference Ranges|Click here for a detailed table.]]

Contact the Haematology Department for advice on interpretation of Neonatal and paediatric coagulation results (to 16 years).

== Contacts ==
Haematology Laboratory

Phone 06 878 1308 Ext 2445

'''Grace Lim'''

Head of Department

(06) 878 1647 or internal ext 6249

== Consultant Haematologist Clinical cover ==
Health New Zealand - Mid-Central Hospital provides a 24 hour specialist cover for clinicians and laboratory staff.

The following Haematologists can be contacted at (06) 350 8550 option 4

Dr Bart Baker

Dr Elayne Knottenbelt

Dr Allanah Kilfoyle

Dr Matt Stephens

Tests:Bone Marrow Aspiration / Trephine Biopsy

2024-06-16T21:21:37Z

Glim:

{{DISPLAYTITLE:Bone Marrow Aspiration / Trephine Biopsy}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|BM, BMA, BMT, Marrow, Bone Marrow, Marrow Aspirate
|-
|'''Specimen'''
|Please contact Haematology to discuss
|-
|'''Paediatric Specimen'''
|Please contact Haematology to discuss
|-
|'''Minimum Volumes'''
|Please contact Haematology to discuss
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|By arrangement
|-
|'''Turnaround Time'''
|Please contact Haematology for more information
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|TBM
|-
|'''Deletion Code'''
|1119
|-
|'''Useful Information'''
|Bone marrows are referred to MidCentral, Palmerston North.
Haematologist approval is required for all bone marrow requests.
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Bone Marrow Aspiration / Trephine Biopsy

2024-06-16T21:17:16Z

Glim:

{{DISPLAYTITLE:Bone Marrow Aspiration / Trephine Biopsy}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|BM, BMA, BMT, Marrow, Bone Marrow, Marrow Aspirate
|-
|'''Specimen'''
|Please contact Haematology to discuss
|-
|'''Paediatric Specimen'''
|Please contact Haematology to discuss
|-
|'''Minimum Volumes'''
|Please contact Haematology to discuss
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|By arrangement
|-
|'''Turnaround Time'''
|Please contact Haematology for more information
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|TBM
|-
|'''Deletion Code'''
|1119
|-
|'''Useful Information'''
|[https://pathologytestsexplained.org.au/learning/test-index/bone-marrow Click Here]
|-
|'''Measurement Uncertainty'''
|N/A
|}

Tests:Bone Marrow Aspiration / Trephine Biopsy

2024-06-16T21:16:54Z

Glim:

{{DISPLAYTITLE:Bone Marrow Aspiration / Trephine Biopsy}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|BM, BMA, BMT, Marrow, Bone Marrow, Marrow Aspirate
|-
|'''Specimen'''
|Please contact Haematology to discuss
|-
|'''Paediatric Specimen'''
|Please contact Haematology to discuss
|-
|'''Minimum Volumes'''
|Please contact Haematology to discuss
|-
|'''Add-on conditions'''
|N/A
|-
|'''Test Availability'''
|By arrangement
|-
|'''Turnaround Time'''
|Please contact Haematology for more information
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|TBM
|-
|'''Deletion Code'''
|1119 + 0855
|-
|'''Useful Information'''
|[https://pathologytestsexplained.org.au/learning/test-index/bone-marrow Click Here]
|-
|'''Measurement Uncertainty'''
|N/A
|}

Coagulation reference ranges

2024-06-14T04:32:59Z

Glim:

{| class="wikitable"
|'''Parameter'''
|'''Units'''
|'''Normal range'''
|'''Therapeutic range'''
|-
|INR
|Ratio
|0.8 - 1.2
|2.0 - 3.0*
|-
|APTT
|Seconds
|24-38
|50 - 85 secs
|-
|FIBRINOGEN
|g/L
|1.5-4.0
|N/A
|-
|TCT
|Seconds
|15 - 21
|N/A
|-
|D DIMER
|ug/L
|< 500
|N/A
|-
|FVIII
|iu/dl
|50 - 150
|N/A
|}
<nowiki>*</nowiki>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.

Reviewed September 2023

CBC Reference Ranges

2024-05-31T03:08:20Z

Glim: As per HPNNZ decisions - removed antenatal ranges

{| class="wikitable"
|'''Age'''
|'''Hb Female (g/L)'''
|'''Hb Male (g/L)'''
|'''HCT Female (Ratio)'''
|'''HCT Male (Ratio)'''
|'''RCC Female'''
|'''RCC Male'''
|'''MCV (fL)'''
|'''MCH (pg)'''
|'''MCHC'''
|'''RDW'''
|'''Platelets (x109/L)'''
|-
|
|
|
|
|
|'''(x1012/L)'''
|'''(x1012/L)'''
|
|
|
|
|
|-
|'''Cord'''
|'''124-192'''
|'''124-192'''
|'''0.37-0.56'''
|'''0.37-0.56'''
|'''3.53-5.52'''
|'''3.53-5.52'''
|'''99-119'''
|'''32-39'''
|'''305-345'''
|'''15.2-19.0'''
|'''150-400'''
|-
|'''1 month'''
|'''93-158'''
|'''93-158'''
|'''0.27-0.46'''
|'''0.27-0.46'''
|'''2.9-4.8'''
|'''2.9-4.8'''
|'''89-100'''
|'''28-34'''
|'''324-364'''
|'''13.2-17.5'''
|'''150-650'''
|-
|'''2-3 months'''
|'''97-130'''
|'''97-130'''
|'''0.29-0.38'''
|'''0.29-0.38'''
|'''3.3-4.8'''
|'''3.3-4.8'''
|'''72-91'''
|'''24-32'''
|'''323-361'''
|'''11.9-16.2'''
|'''150-650'''
|-
|'''4-11 months'''
|'''105-136'''
|'''105-136'''
|'''0.31-0.40'''
|'''0.31-0.40'''
|'''4.0-5.3'''
|'''4.0-5.3'''
|'''69-84'''
|'''22-29'''
|'''315-353'''
|'''12.0-16.0'''
|'''150-575'''
|-
|'''1-3 years'''
|'''105-140'''
|'''105-140'''
|'''0.32-0.41'''
|'''0.32-0.41'''
|'''4.0-5.4'''
|'''4.0-5.4'''
|'''70-86'''
|'''23-29'''
|'''317-353'''
|'''12-15.5'''
|'''150-500'''
|-
|'''4-7 years'''
|'''113-145'''
|'''113-145'''
|'''0.33-0.42'''
|'''0.33-0.42'''
|'''4.1-5.4'''
|'''4.1-5.4'''
|'''74-87'''
|'''24-29'''
|'''319-353'''
|'''12-14.5'''
|'''150-475'''
|-
|'''8-12 years'''
|'''115-145'''
|'''115-145'''
|'''0.35-0.43'''
|'''0.35-0.43'''
|'''4.2-5.6'''
|'''4.2-5.6'''
|'''75-90'''
|'''24-30'''
|'''315-350'''
|'''12-14.5'''
|'''150-425'''
|-
|'''13-15 years'''
|'''115-150'''
|'''125-160'''
|'''0.35-0.44'''
|'''0.37-0.47'''
|'''4-5.35'''
|'''4.4-5.7'''
|'''78-93'''
|'''25-31'''
|'''315-350*'''
|'''12.0-14.5'''
|'''150-400'''
|-
|'''16+ (Adult)'''
|'''115-155'''
|'''130-175'''
|'''0.35-0.46'''
|'''0.40-0.52'''
|'''3.6-5.6'''
|'''4.3-6.0'''
|'''80-99'''
|'''27-33'''
|'''300-365'''
|'''11.5-15.0'''
|'''150-400'''
|}
{| class="wikitable"
|'''Age'''

|'''WCC (x109/L)'''
|'''Neutrophils (x109/L)'''
|'''Lymphs (x109/L)'''
|'''Monocytes (x109/L)'''
|'''Eosinophils (x109/L)'''
|'''Basophils (x109/L)'''
|-
|'''Cord'''
|7.3-25.8
|3.3-13.0
|2.1-10.7
|0.7-2.7
|0.0-1.0
|0.0-0.2
|-
|'''1 month'''
|5.8-13.0
|0.5-3.9
|3.7-8.0
|0.5-1.5
|0.0-0.9
|0.0-0.2
|-
|'''2-3 months'''
|6.6-15.0
|0.8-4.7
|4.2-10.6
|0.4-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-11 months'''
|6.4-17.0
|0.9-5.9
|3.5-11.5
|0.3-1.5
|0.0-0.9
|0.0-0.2
|-
|'''1-3 years'''
|5.0-14.5
|1.0-7.0
|2.0-8.0
|0.3-1.3
|0.0-0.9
|0.0-0.2
|-
|'''4-7 years'''
|4.5-12.0
|1.5-8.0
|1.4-5.7
|0.3-1.0
|0.0-1.0
|0.0-0.2
|-
|'''8-12 years'''
|4.3-12.0
|1.5-7.0
|1.4-4.5
|0.3-0.9
|0.0-0.9
|0.0-0.2
|-
|'''13-15 years'''
|4.2-10.0
|1.8-7.0
|1.4-4.0
|0.3-0.9
|0.0-0.8
|0.0-0.2
|-
|'''16+ (Adult)'''
|4.0-11.0
|1.9-7.5
|1.0-4.0
|0.2-1.0
|0.0-0.5
|0.0-0.2
|}
<nowiki>*</nowiki> MCHC 13-15 years Female 315-350 Male 318-353

Reticulocytes (x 109/L)

Adult 15 - 100

PDW 15.3 - 18.0

MPV 7.4 - 10.4 (platelets normal or high)

9.4 - 14.4 (for low platelet counts)
{| class="wikitable"
|+
!ESR mm/hr
!mm/hr
|-
|1-30 years
|1-10
|-
|31-50 years
|1-15
|-
|51-70 years
|1-20
|-
|71+ years
|1-30
|}
Reviewed September 2023

Tests:Factor VIII Inhibitor assay

2024-05-12T23:43:26Z

Glim:

{{DISPLAYTITLE:Factor VIII Inhibitor Assay}}

[[Category:Tests]]
[[Category:Haematology]]
[[Category:CHL]]

{| class="wikitable"
|'''Synonym(s)'''
|Coagulation Inhibitor Assay, Bethesda, Acquired Haemophilia A
|-
|'''Specimen'''
|2 X 2.7 mL sodium citrate tubes ONLY (Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tubes must be FULL
Separated plasma - 2mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Referred test - [https://www.chl.co.nz/test/factor-viii-inhibitor-assay-plasma/ Refer to CHL website]
|-
|'''Turnaround Time'''
|Referred test - [https://www.chl.co.nz/test/factor-viii-inhibitor-assay-plasma/ Refer to CHL website]
|-
|'''Where analysed'''
|CHL
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|COAG
|-
|'''Deletion Code'''
|7182
|-
|'''Useful Information'''
|
|-
|'''Measurement Uncertainty'''
|N/A
|-
|'''Lab Notes'''
|This is not the same as an inhibitor screen, (screens are done in Hastings). One 2.7ml citrated (BLUE top) collection tube is required. The sample is registered for a sendaway test (registration code COAG) - Refer to senior Haematology staff for advice as other testing may be required.
|}

Tests:Factor IX Assay

2024-05-12T23:42:24Z

Glim:

{{DISPLAYTITLE:Factor IX Assay}}

[[Category:Tests]]
[[Category:Haematology]]
[[Category:CHL]]
{| class="wikitable"
|'''Synonym(s)'''
|Factor 9, Christmas Factor, Haemophilia B, Christmas Disease
|-
|'''Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tube must be FULL
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Referred to CHL - [https://www.chl.co.nz/test/factor-ix-assay-plasma/ Refer to CHL website]
|-
|'''Turnaround Time'''
|Referred to CHL - [https://www.chl.co.nz/test/factor-ix-assay-plasma/ Refer to CHL website]
|-
|'''Where analysed'''
|CHL
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|COAG + AI, HFIB
|-
|'''Deletion Code'''
|7189
|-
|'''Useful Information'''
|[https://pathologytestsexplained.org.au/learning/test-index/coag-factors Click Here]
|-
|'''Measurement Uncertainty'''
|Referred to CHL - [https://www.chl.co.nz/test/factor-ix-assay-plasma/ Refer to CHL website]
|-
|'''Lab Notes'''
|One 2.7ml citrated (BLUE top) collection tube is required. The sample is registered for an INR, APTT, fibrinogen, and sendaway coag. Registration codes AI, HFIB, COAG
|}

Tests:Factor VIII Assay

2024-05-12T23:41:40Z

Glim: lab notes section

{{DISPLAYTITLE:Factor VIII Assay}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|Factor 8, Haemophilic Factor, Haemophilia A
|-
|'''Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tube must be FULL
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Weekly on Thursday (unless urgent - contact Haematology)
|-
|'''Turnaround Time'''
|Hastings / Central HB / Wairoa 1 - 7 days
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|HF8 (will automatically add APTT)
|-
|'''Deletion Code'''
|7189
|-
|'''Useful Information'''
|[https://pathologytestsexplained.org.au/learning/test-index/coag-factors Click Here]
|-
|'''Measurement Uncertainty'''
|Available upon request
|-
|'''Lab Notes'''
|One 2.7ml citrated (BLUE top) collection tube is required. The sample is registered for HF8 and other coagulation tests as requested on the form.
|}

Tests:Infectious Mononucleosis Screen

2023-12-04T01:31:11Z

Glim:

Tests:Factor IX Assay

2023-11-06T02:10:19Z

Glim:

{{DISPLAYTITLE:Factor IX Assay}}

[[Category:Tests]]
[[Category:Haematology]]
[[Category:CHL]]
{| class="wikitable"
|'''Synonym(s)'''
|Factor 9, Christmas Factor, Haemophilia B, Christmas Disease
|-
|'''Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volume'''
|Citrate tube must be FULL
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Referred to CHL - [https://www.chl.co.nz/test/factor-ix-assay-plasma/ Refer to CHL website]
|-
|'''Turnaround Time'''
|Referred to CHL - [https://www.chl.co.nz/test/factor-ix-assay-plasma/ Refer to CHL website]
|-
|'''Where analysed'''
|CHL
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|COAG
|-
|'''Deletion Code'''
|7189
|-
|'''Useful Information'''
|[https://pathologytestsexplained.org.au/learning/test-index/coag-factors Click Here]
|-
|'''Measurement Uncertainty'''
|Referred to CHL - [https://www.chl.co.nz/test/factor-ix-assay-plasma/ Refer to CHL website]
|-
|'''Lab Notes'''
|One 2.7ml citrated (BLUE top) collection tube is required. The sample is registered for an INR, APTT, fibrinogen, and sendaway coag. Registration codes AI, HFIB, COAG
|}

Tests:Coagulation Screen

2023-11-06T02:07:41Z

Glim:

{{DISPLAYTITLE:Coagulation Screen}}
{| class="wikitable"
|'''Test'''
|Coagulation Screen
|-
|'''Synonym(s)'''
|Clotting Screen, Clotting Studies, Coag, coags
|-
|'''Specimen'''
|2.7 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|1.8 mL Sodium Citrate ONLY (Blue top - Must be FULL)
|-
|'''Minimum Volumes'''
|Citrate tube must be FULL
Separated plasma - 1mL
|-
|'''Add-on conditions'''
|4 hours @ 4°C
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|AI
|-
|'''Deletion Code'''
|7173
|-
|'''Useful Information'''
|Samples that will take longer than 4 hours to arrive at the Hastings Laboratory should be separated and frozen for transport
|-
|'''Measurement Uncertainty'''
|Available upon request
|}
[[Category:Tests]]
[[Category:Haematology]]

Tests:Thrombin Clotting Time

2023-11-06T02:05:59Z

Glim:

{{DISPLAYTITLE:Thrombin Clotting Time}}

[[Category:Tests]]
[[Category:Haematology]]
{| class="wikitable"
|'''Synonym(s)'''
|TCT, TT
|-
|'''Specimen'''
|2.7 mL Sodium Citrate (Blue top - Must be FULL)
|-
|'''Paediatric Specimen'''
|1.8 mL Sodium Citrate (Blue top - Must be FULL)
|-
|'''Add-on conditions'''
|8 hours
|-
|'''Test Availability'''
|Mon - Sun, 24 hours
|-
|'''Turnaround Time'''
|Hastings 1 - 2.5 hours / Central HB 6 - 8 hours / Wairoa 12 hours
|-
|'''Where analysed'''
|Hastings
|-
|'''Department'''
|Haematology, (06) 878 1308 ext. 2445
|-
|'''Registration Code'''
|HTCT
|-
|'''Deletion Code'''
|7177
|-
|'''Useful Information'''
|Samples that will take longer than 8 hours to arrive at the Hastings Laboratory should be separated and frozen for transport.
|-
|'''Measurement Uncertainty'''
|Available upon request
|}